|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 227.37 USD | +2.29% |
|
+3.00% | +39.40% |
| 11/07 | Holtec Nuclear Corporation files for US IPO amid surging power demand | RE |
| 11/07 | Holtec Nuclear Corporation files for US IPO | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 25.24 | 22.32 | 11.48 | 5.37 | 4.81 | |||||
Return on Total Capital | 31 | 27.65 | 14.05 | 6.47 | 5.74 | |||||
Return On Equity % | 55.14 | 47.29 | 23.57 | 10.65 | 9.36 | |||||
Return on Common Equity | 54.79 | 46.72 | 22.91 | 9.79 | 8.43 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.28 | 30.18 | 22.59 | 13.41 | 12.03 | |||||
SG&A Margin | 4.74 | 4.87 | 4.64 | 3.71 | 3.84 | |||||
EBITDA Margin % | 27.91 | 27.87 | 21.31 | 14.1 | 12.74 | |||||
EBITA Margin % | 25.78 | 25.64 | 18.63 | 10.55 | 8.96 | |||||
EBIT Margin % | 25.43 | 25.08 | 17.95 | 9.69 | 8.18 | |||||
Income From Continuing Operations Margin % | 19.52 | 19.46 | 14.15 | 7.55 | 6.27 | |||||
Net Income Margin % | 18.71 | 18.33 | 13.03 | 6.6 | 5.37 | |||||
Net Avail. For Common Margin % | 18.62 | 18.25 | 12.99 | 6.57 | 5.35 | |||||
Normalized Net Income Margin | 14.99 | 14.3 | 10.18 | 5.23 | 4.16 | |||||
Levered Free Cash Flow Margin | 9.09 | 14.11 | 10.23 | 0.86 | -2.78 | |||||
Unlevered Free Cash Flow Margin | 9.37 | 14.44 | 10.67 | 1.32 | -2.45 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.59 | 1.42 | 1.02 | 0.89 | 0.94 | |||||
Fixed Assets Turnover | 4.8 | 4.63 | 3.33 | 2.51 | 2.26 | |||||
Receivables Turnover (Average Receivables) | 11.86 | 11.15 | 10.61 | 10.92 | 11.24 | |||||
Inventory Turnover (Average Inventory) | 5.31 | 5.06 | 4.87 | 4.98 | 5.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.48 | 3.39 | 3.57 | 2.51 | 2.94 | |||||
Quick Ratio | 1.28 | 2.08 | 2.27 | 1.41 | 1.47 | |||||
Operating Cash Flow to Current Liabilities | 1.21 | 2.33 | 1.55 | 0.8 | 0.81 | |||||
Days Sales Outstanding (Average Receivables) | 30.78 | 32.73 | 34.41 | 33.51 | 32.46 | |||||
Days Outstanding Inventory (Average Inventory) | 68.73 | 72.18 | 74.92 | 73.46 | 67.47 | |||||
Average Days Payable Outstanding | 19.98 | 21.29 | 24.81 | 26.96 | 23.47 | |||||
Cash Conversion Cycle (Average Days) | 79.53 | 83.63 | 84.51 | 80.01 | 76.46 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 40.56 | 35.56 | 31.41 | 33 | 32.77 | |||||
Total Debt / Total Capital | 28.86 | 26.23 | 23.9 | 24.81 | 24.68 | |||||
LT Debt/Equity | 34.48 | 34.21 | 30.42 | 26.97 | 31.69 | |||||
Long-Term Debt / Total Capital | 24.53 | 25.24 | 23.15 | 20.28 | 23.87 | |||||
Total Liabilities / Total Assets | 43.45 | 39.75 | 37.4 | 36.9 | 36.98 | |||||
EBIT / Interest Expense | 56.87 | 47.55 | 25.33 | 13.07 | 15.64 | |||||
EBITDA / Interest Expense | 62.58 | 52.97 | 30.2 | 19.14 | 24.54 | |||||
(EBITDA - Capex) / Interest Expense | 52.63 | 44.07 | 21.2 | 5.22 | 4.41 | |||||
Total Debt / EBITDA | 0.58 | 0.6 | 0.94 | 1.62 | 1.74 | |||||
Net Debt / EBITDA | 0.32 | 0.18 | -0.02 | 0.67 | 1.09 | |||||
Total Debt / (EBITDA - Capex) | 0.69 | 0.72 | 1.33 | 5.93 | 9.67 | |||||
Net Debt / (EBITDA - Capex) | 0.38 | 0.22 | -0.03 | 2.46 | 6.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 81.15 | 13.78 | -16.38 | -11.47 | 5.73 | |||||
Gross Profit, 1 Yr. Growth % | 391.21 | 13.4 | -37.41 | -47.46 | -5.15 | |||||
EBITDA, 1 Yr. Growth % | 321.4 | 13.59 | -36.04 | -41.41 | -4.52 | |||||
EBITA, 1 Yr. Growth % | 457.4 | 13.17 | -39.24 | -49.89 | -10.12 | |||||
EBIT, 1 Yr. Growth % | 478.32 | 12.22 | -40.15 | -52.18 | -10.74 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 751.93 | 13.44 | -39.2 | -52.8 | -12.12 | |||||
Net Income, 1 Yr. Growth % | 846.33 | 11.42 | -40.52 | -55.2 | -13.96 | |||||
Normalized Net Income, 1 Yr. Growth % | 595.99 | 8.52 | -40.47 | -54.5 | -15.83 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 879.5 | 24.29 | -37.47 | -53 | -11.11 | |||||
Accounts Receivable, 1 Yr. Growth % | 67.65 | -6.82 | -17.76 | -9.41 | 16.07 | |||||
Inventory, 1 Yr. Growth % | 68.42 | -9.28 | 2.28 | -8.46 | 6.97 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 17.36 | 18.41 | 14.76 | 19.7 | 15.54 | |||||
Total Assets, 1 Yr. Growth % | 28.31 | 25.78 | 8.81 | -3.96 | 3.43 | |||||
Tangible Book Value, 1 Yr. Growth % | 27.81 | 10.78 | 24.09 | -7.15 | 6.89 | |||||
Common Equity, 1 Yr. Growth % | 29.92 | 31.38 | 13.72 | -3.09 | 3.16 | |||||
Cash From Operations, 1 Yr. Growth % | 131.04 | 61.65 | -29.39 | -44.05 | -18.72 | |||||
Capital Expenditures, 1 Yr. Growth % | 5.1 | 20.09 | 13.67 | 43.32 | 7.85 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.07T | 76.65 | -41.04 | -92.58 | -443 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 783.45 | 75.39 | -39.86 | -89.05 | -296.4 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.36 | 17.2 | 2.98 | 4.83 | 1.84 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 27.09 | 43.57 | -2.46 | -13.96 | -3.25 | |||||
Gross Profit, 2 Yr. CAGR % | 102.26 | 136.01 | -15.75 | -42.65 | -29.41 | |||||
EBITDA, 2 Yr. CAGR % | 94.12 | 119.62 | -14.76 | -38.78 | -25.21 | |||||
EBITA, 2 Yr. CAGR % | 115.86 | 152.53 | -17.08 | -44.82 | -32.89 | |||||
EBIT, 2 Yr. CAGR % | 119.08 | 156.21 | -18.05 | -46.51 | -34.67 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 127.93 | 210.87 | -16.95 | -46.42 | -35.59 | |||||
Net Income, 2 Yr. CAGR % | 131.76 | 224.72 | -18.59 | -48.38 | -37.92 | |||||
Normalized Net Income, 2 Yr. CAGR % | 129.92 | 176.84 | -19.63 | -47.96 | -38.12 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 136.59 | 248.92 | -11.84 | -45.79 | -35.36 | |||||
Accounts Receivable, 2 Yr. CAGR % | 33.57 | 24.98 | -12.46 | -13.69 | 2.54 | |||||
Inventory, 2 Yr. CAGR % | 25.08 | 23.61 | -3.67 | -3.24 | -1.05 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.41 | 17.89 | 16.57 | 17.2 | 17.6 | |||||
Total Assets, 2 Yr. CAGR % | 18.64 | 27.04 | 16.99 | 2.22 | -0.33 | |||||
Tangible Book Value, 2 Yr. CAGR % | 16.63 | 18.99 | 17.25 | 7.34 | -0.38 | |||||
Common Equity, 2 Yr. CAGR % | 16.33 | 30.65 | 22.23 | 4.98 | -0.01 | |||||
Cash From Operations, 2 Yr. CAGR % | 48.92 | 93.25 | 6.84 | -37.15 | -32.57 | |||||
Capital Expenditures, 2 Yr. CAGR % | 4.78 | 12.35 | 16.84 | 27.63 | 24.32 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 90.14 | 364.58 | 3.47 | -79.09 | -49.56 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 83.45 | 299.55 | 4.1 | -74.33 | -53.62 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.45 | 11.65 | 9.86 | 3.9 | 3.33 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.33 | 22.49 | 19.9 | -5.56 | -7.84 | |||||
Gross Profit, 3 Yr. CAGR % | 37.01 | 66.78 | 51.64 | -28.02 | -32.18 | |||||
EBITDA, 3 Yr. CAGR % | 34.83 | 62.37 | 45.57 | -24.77 | -29.01 | |||||
EBITA, 3 Yr. CAGR % | 40.2 | 74.06 | 57.07 | -29.89 | -35.08 | |||||
EBIT, 3 Yr. CAGR % | 40.78 | 75.29 | 57.79 | -31.52 | -36.55 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.12 | 80.63 | 80.46 | -31.2 | -36.81 | |||||
Net Income, 3 Yr. CAGR % | 42.47 | 81.56 | 84.41 | -33.29 | -38.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | 42.29 | 79.01 | 65.85 | -33.51 | -38.91 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 46.12 | 90.9 | 96.72 | -28.52 | -36.08 | |||||
Accounts Receivable, 3 Yr. CAGR % | 15.43 | 18.46 | 8.71 | -11.46 | -4.73 | |||||
Inventory, 3 Yr. CAGR % | 9.7 | 12.38 | 16.05 | -5.29 | 0.05 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.44 | 15.73 | 16.83 | 17.61 | 16.65 | |||||
Total Assets, 3 Yr. CAGR % | 12.95 | 20.98 | 20.64 | 9.54 | 2.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.16 | 14.64 | 20.67 | 8.47 | 7.19 | |||||
Common Equity, 3 Yr. CAGR % | 12.7 | 21.14 | 24.74 | 13.13 | 4.37 | |||||
Cash From Operations, 3 Yr. CAGR % | 37.55 | 53.05 | 38.16 | -13.89 | -31.52 | |||||
Capital Expenditures, 3 Yr. CAGR % | 18.19 | 9.66 | 12.79 | 25.07 | 20.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 48.56 | 85.53 | 135.61 | -57.02 | -46.87 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 45.39 | 80.73 | 114.45 | -50.85 | -49.42 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.65 | 7.84 | 8.68 | 8.16 | 3.21 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.62 | 15.44 | 6.73 | 6.35 | 10.04 | |||||
Gross Profit, 5 Yr. CAGR % | 40.39 | 37.28 | 12.79 | 8.82 | 11.69 | |||||
EBITDA, 5 Yr. CAGR % | 36.49 | 34.7 | 12.24 | 9.91 | 11.53 | |||||
EBITA, 5 Yr. CAGR % | 43.67 | 40.09 | 13.64 | 9.93 | 11.78 | |||||
EBIT, 5 Yr. CAGR % | 44.69 | 40.79 | 13.38 | 9.04 | 10.89 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 51.23 | 42.39 | 14.64 | 11.09 | 19.51 | |||||
Net Income, 5 Yr. CAGR % | 53.69 | 41.98 | 13.9 | 9.78 | 19.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | 49.65 | 41.89 | 13.23 | 9.22 | 11.81 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 56.32 | 47.69 | 19.38 | 15.38 | 26.04 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.76 | 12.1 | 3.34 | 4.37 | 6.2 | |||||
Inventory, 5 Yr. CAGR % | 19.37 | 9.52 | 4.14 | 5.85 | 8.88 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.08 | 13.79 | 15.89 | 16.32 | 17.14 | |||||
Total Assets, 5 Yr. CAGR % | 11.15 | 15.44 | 14.55 | 13.09 | 11.77 | |||||
Tangible Book Value, 5 Yr. CAGR % | 15.25 | 14.7 | 15.38 | 11.66 | 11.76 | |||||
Common Equity, 5 Yr. CAGR % | 12.21 | 16.08 | 16.42 | 14.4 | 14.18 | |||||
Cash From Operations, 5 Yr. CAGR % | 28.91 | 57.02 | 24.33 | 7.21 | 3.7 | |||||
Capital Expenditures, 5 Yr. CAGR % | 21.81 | 34.14 | 17.64 | 16.52 | 17.27 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 30.27 | 80.13 | 28.55 | -22.09 | 27.18 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 27.94 | 69.7 | 27.2 | -16.76 | 16.24 | |||||
Dividend Per Share, 5 Yr. CAGR % | 2.68 | 5.85 | 6.09 | 6.25 | 6.51 |
- Stock Market
- Stocks
- NUE Stock
- Financials Nucor Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















